Rosalind Advisors Inc. 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-20 4:23 pm Purchase | 2021-12-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Rosalind Advisors Inc. | 96,948 6.500% | 15,692 (+19.31%) | Filing |
| 2021-09-23 4:54 pm Purchase | 2021-09-14 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Rosalind Advisors Inc. | 81,256 5.600% | 81,256 (New Position) | Filing |